Properties of HPMA copolymer–doxorubicin conjugates with pH-controlled activation: Effect of polymer chain modification
- 28 September 2006
- journal article
- Published by Elsevier BV in Journal of Controlled Release
- Vol. 115 (1), 26-36
- https://doi.org/10.1016/j.jconrel.2006.06.028
Abstract
No abstract availableKeywords
This publication has 17 references indexed in Scilit:
- Chemotherapy based on HPMA copolymer conjugates with pH-controlled release of doxorubicin triggers anti-tumor immunityJournal of Controlled Release, 2005
- Antibody-targeted Polymer–doxorubicin Conjugates with pH-controlled ActivationJournal of Drug Targeting, 2004
- Polyacetal−Doxorubicin Conjugates Designed for pH-Dependent DegradationBioconjugate Chemistry, 2003
- HPMA copolymers with pH-controlled release of doxorubicinJournal of Controlled Release, 2002
- Physical properties and in vitro transfection efficiency of gene delivery vectors based on complexes of DNA with synthetic polycationsJournal of Controlled Release, 2002
- Doxorubicin bound to a HPMA copolymer carrier through hydrazone bond is effective also in a cancer cell line with a limited content of lysosomesJournal of Controlled Release, 2001
- New HPMA copolymers containing doxorubicin bound via pH-sensitive linkage: synthesis and preliminary in vitro and in vivo biological propertiesJournal of Controlled Release, 2001
- HPMA copolymer–anticancer drug conjugates: design, activity, and mechanism of actionEuropean Journal of Pharmaceutics and Biopharmaceutics, 2000
- Polymeric drugs based on conjugates of synthetic and natural macromolecules: I. Synthesis and physico-chemical characterisationJournal of Controlled Release, 2000
- Polymers containing enzymatically degradable bonds, XII. Effect of spacer structure on the rate of release of daunomycin and adriamycin from poly [N-(2-hydroxypropyl)-methacrylamide] copolymer drag carriers in vitro and antitumour activity measured in vivoJournal of Controlled Release, 1992